150 related articles for article (PubMed ID: 27555663)
21. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men.
Nobata S; Hishida A; Naito M; Asai Y; Mori A; Kuwabara M; Katase S; Okada R; Morita E; Kawai S; Hamajima N; Wakai K
Urol Int; 2012; 89(1):39-44. PubMed ID: 22433834
[TBL] [Abstract][Full Text] [Related]
22. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
[TBL] [Abstract][Full Text] [Related]
23. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
Bonk S; Kluth M; Jansen K; Hube-Magg C; Makrypidi-Fraune G; Höflmayer D; Weidemann S; Möller K; Uhlig R; Büscheck F; Luebke AM; Burandt E; Clauditz TS; Steurer S; Schlomm T; Huland H; Heinzer H; Sauter G; Simon R; Dum D
Prostate; 2020 Sep; 80(13):1097-1107. PubMed ID: 32628300
[TBL] [Abstract][Full Text] [Related]
24. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
[TBL] [Abstract][Full Text] [Related]
25. MMP26: A potential biomarker for prostate cancer.
Cheng T; Li F; Wei R; Lv MQ; Zhou Y; Dai Y; Yuan Y; Jiang GY; Ma D; Gao QL
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):891-894. PubMed ID: 29270749
[TBL] [Abstract][Full Text] [Related]
26. Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.
O'Mara TA; Nagle CM; Batra J; Kedda MA; Clements JA; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):323-7. PubMed ID: 21787114
[TBL] [Abstract][Full Text] [Related]
27. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
Olkhov-Mitsel E; Van der Kwast T; Kron KJ; Ozcelik H; Briollais L; Massey C; Recker F; Kwiatkowski M; Fleshner NE; Diamandis EP; Zlotta AR; Bapat B
Epigenetics; 2012 Sep; 7(9):1037-45. PubMed ID: 22874102
[TBL] [Abstract][Full Text] [Related]
28. Analysis of fusion gene expression in prostate tumors by using single-end reads.
Xie DD; Li JY; Wang Y; Chen L; Yu DX
Genet Mol Res; 2013 Aug; 12(3):2886-94. PubMed ID: 24065644
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer.
Matin F; Jeet V; Srinivasan S; Cristino AS; Panchadsaram J; Clements JA; Batra J;
Clin Chem; 2019 Jun; 65(6):771-780. PubMed ID: 31018918
[TBL] [Abstract][Full Text] [Related]
30. Kallikrein gene expression in human pituitary tissues.
Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.
Wilson MJ
J Lab Clin Med; 1998 Apr; 131(4):298-9. PubMed ID: 9579381
[No Abstract] [Full Text] [Related]
32. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
[TBL] [Abstract][Full Text] [Related]
33. KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?
Koistinen H; Künnapuu J; Jeltsch M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948344
[TBL] [Abstract][Full Text] [Related]
34. Kallikreins as biomarkers for prostate cancer.
Hong SK
Biomed Res Int; 2014; 2014():526341. PubMed ID: 24809052
[TBL] [Abstract][Full Text] [Related]
35. Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis.
Li H; Fei X; Shen Y; Wu Z
Adv Clin Exp Med; 2020 Aug; 29(8):1001-1009. PubMed ID: 32869960
[TBL] [Abstract][Full Text] [Related]
36. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins.
David A; Mabjeesh N; Azar I; Biton S; Engel S; Bernstein J; Romano J; Avidor Y; Waks T; Eshhar Z; Langer SZ; Lifschitz-Mercer B; Matzkin H; Rotman G; Toporik A; Savitsky K; Mintz L
J Biol Chem; 2002 May; 277(20):18084-90. PubMed ID: 11834722
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility.
Gupta N; Sudhakar DVS; Gangwar PK; Sankhwar SN; Gupta NJ; Chakraborty B; Thangaraj K; Gupta G; Rajender S
Sci Rep; 2017 Sep; 7(1):11225. PubMed ID: 28894123
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract][Full Text] [Related]
39. Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group.
Benli E; Bayrak A; Cirakoglu A; Bayrak T; Noyan T
Kaohsiung J Med Sci; 2017 Nov; 33(11):572-577. PubMed ID: 29050675
[TBL] [Abstract][Full Text] [Related]
40. Genetic correction of PSA values using sequence variants associated with PSA levels.
Gudmundsson J; Besenbacher S; Sulem P; Gudbjartsson DF; Olafsson I; Arinbjarnarson S; Agnarsson BA; Benediktsdottir KR; Isaksson HJ; Kostic JP; Gudjonsson SA; Stacey SN; Gylfason A; Sigurdsson A; Holm H; Bjornsdottir US; Eyjolfsson GI; Navarrete S; Fuertes F; Garcia-Prats MD; Polo E; Checherita IA; Jinga M; Badea P; Aben KK; Schalken JA; van Oort IM; Sweep FC; Helfand BT; Davis M; Donovan JL; Hamdy FC; Kristjansson K; Gulcher JR; Masson G; Kong A; Catalona WJ; Mayordomo JI; Geirsson G; Einarsson GV; Barkardottir RB; Jonsson E; Jinga V; Mates D; Kiemeney LA; Neal DE; Thorsteinsdottir U; Rafnar T; Stefansson K
Sci Transl Med; 2010 Dec; 2(62):62ra92. PubMed ID: 21160077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
